1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. BIOGEN INC
Biogen Inc XNAS: BIIB

Biogen Inc Live Share Price Today, Share Analysis and Chart

Strong Performer, Under Radar
about

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva (oncology) and Ocrevus (multiple sclerosis) are marketed via a colla...

Read More
132.87 -0.32 (-0.24%)
44.17% Fall from 52W High
633.3K
XNAS Volume

XNAS 03 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
High Financial Strength
66.7 / 100
Valuation Score
Affordable Valuation
53.5 / 100
Momentum Score
Technically Neutral
50.9 / 100
Strong Performer, Under Radar These stocks are with good quality scores and with strong financials. They are affordably priced stocks and can give good returns View Similar Embed DVM
Analyst Price Target
171
1Yr Price target upside is 29%
31 analysts

9

S

7

W

2

O

1

T

SWOT Analysis

Biogen Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..